For Release: Immediate
LadyComp Increases Awareness Of Oral Contraception Cancer Risks
LadyComp, the developers of the world’s most advanced natural fertility device, are concerned that women may have become blasé about the possible risks of oral contraceptives due to their longevity in the health system. LadyComp wants to increase awareness of these risks and promote natural contraception as a means for optimal health.
Oral contraceptives have been at the centre of concerns about the risks of related cancer development and, as such, have been under the microscope for the past 18 years. Over this time, considerable research and studies have been undertaken but results have remained inconclusive.
"This means that oral contraceptives cannot be deemed conclusively safe, especially in the long-term," said Tracey Vale, spokesperson for LadyComp. "Questions concerning cancer-risk continue to be raised and investigated."
"We are concerned that women do not know the potential risks of the pill, simply because it has been around for so long and is deemed safe and acceptable in the mainstream.”
"Women should be made more aware of these risks and choose natural birth control for their long-term health and wellbeing,” Vale said.
The National Cancer Institute (U.S.) says "Because medical research suggests that cancers of the female reproductive organs sometimes depend on naturally occurring sex hormones for their development and growth, scientists have been investigating a possible link between OC use and cancer risk." The pill suppresses oestrogen and progesterone production, while the lesser effective mini pill suppresses progesterone.
"A correlation between oestrogen and increased risk of breast cancer has sparked continuing controversy about a possible link between OCs and cancer.”
The Institute says "This scrutiny has produced a wealth of data on OC use and the development of certain cancers, although results have not always been consistent."
The National Cancer Institute’s Fact Sheet cites the following concerns based on past, current and ongoing studies and research:
Oral Contraceptives increase the risk of certain cancers.
- For recent users of oral contraceptives under the age of 35, there is a risk of breast cancer.
- There is evidence that long-term OC use increases the risk of cervical cancer.
- There is some evidence that certain liver tumours may be related to OC use.
LadyComp was developed to offer women a healthy, natural alternative to oral contraceptives and other forms of contraception. OCs are considered to be a burden on the body due to their chemical nature and the fact that they alter the natural status quo of the hormonal system.
“There is no logical reason for a woman to burden her health, or her sex life, with contraceptive measures for a full 28 days, when in fact it is only possible for her to become pregnant on six of these days,” said Vale.
National Cancer Institute, National Institutes of Health, cited at http://womenshealth.about.com/cs/thepill/a/oralcontrcncrri.htm
National Cancer Institute Fact Sheet http://www.cancer.gov/PDF/FactSheet/fs3_13.pdf
Media Contact: Darryn Keneally 0410 344 761